Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced that...
Environmental Impact Acquisition Corporation, a publicly-traded special purpose acquisition company, announced that its business combination with Greenlight Biosciences was approved in a shareholder vote...
Meritor, Inc. announced an extension to its current PACCAR agreement to supply 14Xe™ ePowertrains and battery electric vehicle integration kits for the Class 8...
